Welcome to our dedicated page for Linde Plc SEC filings (Ticker: LIN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Linde plc (Nasdaq: LIN) SEC filings page on Stock Titan brings together the company’s U.S. regulatory disclosures with AI‑supported analysis to help investors interpret complex documents. Linde is an Irish‑incorporated global industrial gases and engineering company whose ordinary shares are listed on The Nasdaq Stock Market LLC under the symbol LIN.
Linde’s current reports on Form 8‑K cover a range of topics relevant to shareholders. Examples include quarterly results announcements furnished under Item 2.02, which reference press releases detailing sales, operating profit, earnings per share, cash flow and segment performance, as well as non‑GAAP reconciliations. Other 8‑K filings describe governance and leadership changes under Item 5.02, such as appointments and retirements of directors and executive officers, and the creation or modification of senior roles like Chief Operating Officer or Chief Human Resources Officer.
Filings also document shareholder matters. For instance, Form 8‑K reports on the annual general meeting of shareholders, summarizing voting results for director elections, advisory votes on executive compensation, auditor ratification and authorizations related to treasury shares. These disclosures provide insight into Linde’s corporate governance practices as an Irish public company.
Capital structure and financing activities appear in 8‑K filings describing the issuance of notes under Linde’s European debt issuance program. These filings outline key terms such as maturities, interest structures, listing on the Luxembourg Stock Exchange’s Euro MTF market, and guarantees provided by subsidiaries Linde GmbH and Linde Inc.
On this page, AI‑powered tools highlight the most important points from Linde’s filings, helping readers quickly identify items related to earnings, governance, financing transactions and shareholder decisions, while links to the underlying SEC documents allow for deeper review when needed.
Linde plc director Stephen F. Angel reported a compensation-related share transaction. On January 20, 2026, 7,248.579 deferred stock units were paid out in Linde ordinary shares at a price of $0 per share under the Linde Compensation Deferral Plan. In connection with this payout, 2,552.269 ordinary shares were withheld at $440.04 per share to cover taxes.
After these transactions, Angel directly owned 460,238.812 Linde ordinary shares. He also reported additional indirect holdings, including 71,029 ordinary shares held through a 2010 Descendants Trust, along with other ordinary shares held in a 2012 Descendants Trust, in trust for children, and in a 401(k) account.
Linde plc reported issuing three euro-denominated note tranches under its European debt issuance programme. The company sold €600 million Floating Rate Notes due 2027, €650 million 3.125% Notes due 2032 and €500 million 3.750% Notes due 2038. Net proceeds were approximately €1,737 million after fees to the managers and will be used for general corporate purposes.
The notes are admitted to the official list of the Luxembourg Stock Exchange and trade on its Euro MTF market. They were issued under Linde’s European debt issuance programme, which permits up to €20 billion aggregate principal amount of notes to be outstanding. Notes issued under the programme are guaranteed by Linde GmbH and Linde Inc. and are offered outside the United States under Regulation S.
Linde plc reported stronger Q3 2025 results. Sales were $8,615 million, up from $8,356 million a year ago. Operating profit rose to $2,367 million from $2,086 million, and net income attributable to Linde increased to $1,929 million. Diluted EPS was $4.09 versus $3.22.
For the first nine months, operating cash flow reached $7,320 million, funding capital expenditures of $3,803 million, share repurchases of $3,205 million, and dividends of $2,113 million. Total debt was $25,925 million at September 30, 2025, up from $21,623 million at year‑end, reflecting new issuances including €850 million 2.625% notes due 2029, €750 million 3.00% notes due 2033, €650 million 3.25% notes due 2037, and CHF225 million 0.6150% notes due 2029 and CHF275 million 1.0629% notes due 2033; Linde also redeemed $600 million 4.700% notes and repaid $400 million 2.65% notes due 2025.
At September 30, 2025, cash and cash equivalents were $4,509 million and 466,948,930 ordinary shares were outstanding. Disclosed contingencies include $1.2 billion related to terminated Russian engineering projects with RCA and $0.7 billion tied to Amur GPP matters; proceedings and arbitrations remain ongoing.
Linde plc furnished an 8-K under Item 2.02 to announce results of operations for the quarter ended September 30, 2025. The company attached a press release dated October 31, 2025 as Exhibit 99.1, which is incorporated by reference.
Linde’s ordinary shares (nominal value €0.001) trade on the Nasdaq Stock Market under the symbol LIN.
Linde plc (LIN) reported an initial statement of beneficial ownership (Form 3) for its SVP, Americas, effective 10/22/2025. The officer holds 12,335.266 ordinary shares directly and 923.986 ordinary shares indirectly via a 401(k).
Reported derivative holdings include Restricted Stock Units for 1,064, 980, and 960 ordinary shares that vest and pay out on or about March 7, 2028, March 7, 2027, and March 7, 2026, respectively, on a one-for-one basis. Stock options are listed across multiple grants, including 7,468 options at an exercise price of $468.77 expiring 03/07/2035, and 6,340 options at $465.29 expiring 03/07/2034, each vesting in three equal annual installments beginning the March following grant. The filing also notes 240.682 deferred stock units payable one-for-one in ordinary shares under the company’s deferral plan.
The form was signed by Anthony M. Pepper as attorney-in-fact.
Linde plc reported upcoming leadership changes at the board and executive levels. Stephen F. Angel, currently Chairman of the Board, announced he will retire from Linde’s Board of Directors effective January 31, 2026. Upon his retirement, CEO Sanjiv Lamba will also become Chairman of the Board, while Robert Wood will continue to serve as Lead Independent Director, preserving an independent leadership role on the board.
Linde also announced that its Board has appointed Sean Durbin, currently Executive Vice President – North America, as Chief Operating Officer effective October 1, 2025, reporting to the CEO. Durbin has held senior roles across North America and EMEA and has been with Praxair and Linde-related businesses since 1993, bringing long operational and regional leadership experience into the new COO position.
Guillermo Bichara, Executive Vice President & Chief Legal Officer of Linde plc (LIN), reported insider transactions dated 09/11/2025. The filing shows a gift disposition of 640 ordinary shares (transaction code G) with $0 received, reducing direct holdings to 22,137.769 ordinary shares. The report also discloses 2,890.178 shares held indirectly in a 401(k) plan. The Form 4 lists outstanding equity awards: restricted stock units totaling 4,863 RSUs scheduled to vest between 2026 and 2028, multiple stock options exercisable through 2035 representing specified share counts, and 794.534 deferred stock units payable one-for-one in ordinary shares under the company deferral plan.
Report summary: This Form 3 discloses initial beneficial ownership by Desiree Bacher, identified as SVP, Chief HR Officer of Linde plc (LIN). She directly holds 139 ordinary shares and beneficial ownership of multiple equity awards including restricted stock units, deferred stock units and stock options.
Specifically, the filing lists restricted stock units that will convert one-for-one to ordinary shares: 309 units vesting ~03/07/2028, 300 units vesting ~03/07/2027, and 260 units vesting ~03/07/2026. Stock options cover 2,168 shares exercisable beginning 03/07/2026 (strike $468.77), 1,920 shares beginning 03/07/2025 ($465.29), and 1,690 shares beginning 03/07/2024 ($354.14). There are also 40.669 deferred stock units under the Linde Compensation Deferral Plan.
Stephen F. Angel, a director of Linde plc (LIN), reported a change in beneficial ownership on Form 4. The filing shows a disposition on 08/18/2025 of 25,000 ordinary shares reported as a charitable gift with no market transaction and a $0 price. After the reported transaction the reporting person holds 455,542.502 ordinary shares directly and additional indirect holdings through trusts and a 401(k), including 71,029 shares via a 2010 Descendants Trust and other indirect interests. The filing also lists multiple outstanding restricted stock units and stock options with specified grant/expiration dates and share amounts.
Enders Thomas, a director of Linde plc (LIN), reported transactions dated 08/18/2025. The filing shows a gift of 2,500 ordinary shares (transaction code G) at a reported price of $0, leaving 10,594.803 ordinary shares beneficially owned following the transfer. The form also reports 467.02 restricted stock units (RSUs) that convert one-for-one into ordinary shares; those RSUs vest in full and pay out in shares one year after the March 7, 2025 grant date, subject to continuous board service with limited pro-rata exceptions. The Form 4 was signed by attorney-in-fact Anthony M. Pepper on 08/19/2025.
FAQ
What is the current stock price of Linde Plc (LIN)?
What is the market cap of Linde Plc (LIN)?
